fbpx

Scientific research works

2024

Pilavdzic A, Pavljasevic S, Nadarevic-Vodencarevic A, Međedovic A, Halilbasic M, Cickusic A, Hodzic N et al.

Med Glas (Zenica), 2024

2023

Zerem E, Kurtcehajic A, Kunosić S, Zerem-Malkočević D, Zerem O

World J Gastroenterol, 2023 

Kurtcehajic A, Zerem E, Alibegović E, Kunosić S, Hujdurović A, Fejzić J A

World J Clin Cases, 2023 

2022

Avdic A, Kurtcehajic A, Hadziavdic V, Hercegovac A, Dautbasic A, Brzovic S et al.

Biotechnology Journal International, 2022

Rahimic J, Alibegovic E, Kurtcehajic A, Lekic L, Alibegovic D, Dautović E

Journal of Pharmaceutical Research International, 2022

Sehanovic L, Hadziahmetovic N, Kurtcehajic A

Journal Human Research in Rehabilitation, 2022

2021

Crnkic D, Alibegovic E, Becic F, Asceric M, Kurtalic S, Kurtcehajic A

Acta Medica Saliniana, 2021

Alibegovic E, Kurtcehajic A, Ilic B, Hujdurovic A, Smajic E, Habibovic A, Perkunic D

Case Reports Hepatol. 2021 Nov

Zerem E, Kunosić S, Imširović B, Kurtcehajic A

Psychiatr Danub. 2021 May;33

Čustović N, Džananović L, Rašić I, Zubčević N, Šaranović-Čečo L, Drljević A, Redžepagić J

Med Glas (Zenica). 2021 Feb 1;18(1).

Nadarević-Vodenčarević A, Halilbašić M, Međedović A, Jusufović V, Pilavdžić A, Drljević A, Burgić M

Med Glas (Zenica). 2021 Feb 1;18(1)

2020

Bokun T, Tadic M, Kurtcehajic A, Grgurevic I, Kujundzic M

Endoscopy. 2020 Dec;52(12):E459-E460.

2018

Alibegovic E, Kurtcehajic A, Hujdurovic A, Mujagic S, Alibegovic J, Kurtcehajic Dz

Am J Med. 2018 Apr;131(4):e175.

Kurtcehajic A, Alibegovic E, Hujdurovic A, Vele E, Kurtcehajic Dz

Am J Med. 2018 Mar;131(3):e119.

2017

Kurtcehajic A, Alibegovic E, Hujdurovic A, Mujagic S, Kurtcehajic Dz

EC Gastroenterology and Digestive System, 2017

Alibegovic E, Kurtcehajic A, Hasukic I, Hujdurovic A, Fejzic J A, Kurtcehajic Dz

Intractable Rare Dis Res. 2017 May;6(2):141-144.

Alibegovic E, Kurtcehajic A, Hujdurovic A, Zeco A, Kurtcehajic Dz

Gastrointest Endosc. 2017 Aug;86(2):409-411.

2016

Kurtcehajic A, Alibegovic E, Hujdurovic A, Fejzic J A, Kurtcehajic S

Medicine (Baltimore), 2016

Vele E, Kurtcehajic A, Zerem E, Maskovic J, Alibegovic E, Hujdurovic A

J Thromb Haemost. 2016 Nov;14(11):2298-2303.

Kurtcehajic A, Zerem E, Boričić I, Hujdurovic A, Zerem O

Am J Gastroenterol. 2016 Sep;111(9):1227.

Kurtcehajic A, Vele E, Hujdurovic A

J Hepatobiliary Pancreat Sci. 2016 Oct;23(10):658.

Kurtcehajic A, Zerem E, Hujdurovic A, Fejzic JA

Eur J Gastroenterol Hepatol. 2016 Jan;28(1):116-8.

2015

Zerem E, Imsirovic B, Loga-Zec S, Kunosic S, Hujdurović A, Zerem O

Annals of the Academy of Medicine Singapore, 2015

Zerem E, Lincender-Cvijetić L, Kurtcehajic A, Samardžić J, Zerem O

J Clin Gastroenterol. 2015 Oct;49(9):795-6.

Zerem E, Loga-Zec S, Kunosic S, Kurtcehajic A

J Clin Gastroenterol. 2015 Mar;49(3):259-60.

Kurtcehajic A, Salkic N,  Alibegovic E, Hujdurovic A, Kurtcehajic Dz, Krizic N

Esophagus, Ausgabe 2/2015

Clinical studies

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GUSELKUMAB SUBCUTANEOUS INDUCTION THERAPY IN PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

2022-u toku

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF COBITOLIMOD AS AN INDUCTION AND MAINTENANCE THERAPY IN PARTICIPANTS WITH MODERATE TO SEVERE ACTIVE LEFT-SIDED ULCERATIVE COLITIS

2021-u toku

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSES CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFOZIN (MK-8335/PF-04971724) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE.

2017-2020

Želite zakazati termin?

Kontaktirajte nas pozivom na broj 035 393 111